Hammett JL - Search Results

1

The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects.

Marino MR, Langenbacher KM, Hammett JL, Nichola P, Uderman HD. Marino MR, et al. Among authors: hammett jl. J Clin Psychopharmacol. 1997 Feb;17(1):27-33. doi: 10.1097/00004714-199702000-00006. J Clin Psychopharmacol. 1997. PMID: 9004054

2

The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis.

Sica DA, Marino MR, Hammett JL, Ferreira I, Gehr TW, Ford NF. Sica DA, et al. Among authors: hammett jl. Clin Pharmacol Ther. 1997 Dec;62(6):610-8. doi: 10.1016/S0009-9236(97)90080-1. Clin Pharmacol Ther. 1997. PMID: 9433389 Clinical Trial.

3

Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment.

Ford NF, Lasseter KC, Van Harken DR, Hammett JL, Raymond R, Manning J. Ford NF, et al. Among authors: hammett jl. J Clin Pharmacol. 1995 Feb;35(2):145-50. doi: 10.1002/j.1552-4604.1995.tb05003.x. J Clin Pharmacol. 1995. PMID: 7751424

4

Effects of age and gender on the pharmacodynamics of omapatrilat in healthy volunteers.

Liao W, Vesterqvist O, Manning J Jr, Hammett JL, Ferreira IM, Meier A, Davis KD, Hutman HW. Liao W, et al. Among authors: hammett jl. Am J Geriatr Cardiol. 2001 Jan-Feb;10(1):50-4. doi: 10.1111/j.1076-7460.2001.90856.x. Am J Geriatr Cardiol. 2001. PMID: 11413936

5

The pharmacokinetics of pravastatin in patients on chronic hemodialysis.

Gehr TW, Sica DA, Slugg PH, Hammett JL, Raymond R, Ford NF. Gehr TW, et al. Among authors: hammett jl. Eur J Clin Pharmacol. 1997;53(2):117-21. doi: 10.1007/s002280050348. Eur J Clin Pharmacol. 1997. PMID: 9403282 Clinical Trial.

6

Clinical pharmacokinetics and pharmacodynamics of a new squalene synthase inhibitor, BMS-188494, in healthy volunteers.

Sharma A, Slugg PH, Hammett JL, Jusko WJ. Sharma A, et al. Among authors: hammett jl. J Clin Pharmacol. 1998 Dec;38(12):1116-21. J Clin Pharmacol. 1998. PMID: 11301563 Clinical Trial.

7

Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men.

Dhaun N, Strachan FE, Newby DE, Johnston NR, Ford NF, Hammett JL, Palmisano M, Webb DJ. Dhaun N, et al. Among authors: hammett jl. Br J Clin Pharmacol. 2005 Dec;60(6):611-22. doi: 10.1111/j.1365-2125.2005.02503.x. Br J Clin Pharmacol. 2005. PMID: 16305585 Free PMC article. Clinical Trial.

8

Estimation of oral bioavailability of a long half-life drug in healthy subjects.

Sharma A, Slugg PH, Hammett JL, Jusko WJ. Sharma A, et al. Among authors: hammett jl. Pharm Res. 1998 Nov;15(11):1782-6. doi: 10.1023/a:1011977116543. Pharm Res. 1998. PMID: 9834003 Clinical Trial.

9

Effect of Nifedipine on the Steady-State Pharmacokinetics and Pharmacodynamics of Irbesartan in Healthy Subjects.

Marino MR, Hammett JL, Ferreira I I, Ford NF, Uderman HD. Marino MR, et al. Among authors: hammett jl. J Cardiovasc Pharmacol Ther. 1998 Apr;3(2):111-118. doi: 10.1177/107424849800300203. J Cardiovasc Pharmacol Ther. 1998. PMID: 10684488

10

Measurement of 2,4-toluenediamine in urine and serum samples from women with Même or Replicon breast implants.

Hester TR Jr, Ford NF, Gale PJ, Hammett JL, Raymond R, Turnbull D, Frankos VH, Cohen MB. Hester TR Jr, et al. Among authors: hammett jl. Plast Reconstr Surg. 1997 Oct;100(5):1291-8. doi: 10.1097/00006534-199710000-00035. Plast Reconstr Surg. 1997. PMID: 9326795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters